Results 71 to 80 of about 5,787 (176)
Castlemans Disease- A Case Report
Castlemans disease(CD) is a heterogeneous group of lymphoproliferative disorders of uncertain cause presenting with lymphadenopathy. It is histologically and prognostically distinct from malignant lymph-node hyperplasia.
Md. Ismail Patwary +5 more
doaj +1 more source
Case report of a 30‐year‐old female. Asymptomatic, red‐purple hyperplastic lesion extending from teeth 21 to 25, with bleeding upon manipulation. Differential diagnosis included: inflammatory gingival hyperplasia, plasma cell gingivitis, leukemia, and Wegener's granulomatosis.
Pedro Vinícius Santos de Jesus +8 more
wiley +1 more source
ABSTRACT Kaposi's sarcoma‐associated herpesvirus (KSHV) has been associated with a variety of diseases and is endemic in Sub‐Saharan Africa. We performed KSHV‐whole‐genome analysis and search for APOBEC‐editing to describe genetic diversity in samples issued from an endemic region.
Gervillien Arnold Malonga +11 more
wiley +1 more source
Mesenteric Castleman's Disease
We report here a rare case of mesenteric Castleman's disease presenting as a mesenteric mass. A 13-year-old female child was admitted to our hospital complaining of intermittent vague abdominal pain. She had hypochromic anemia, thrombocytosis and an elevated erythrocyte sedimentation rate (ESR).
Kim, Sung-Hoon +11 more
openaire +2 more sources
Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary
Castleman disease is a rare and atypical lymphoproliferative disorder characterized by diverse clinical manifestations. It has both unicentric and multicentric forms, the latter with further subdivisions, i.e., human herpesvirus 8-associated and ...
Boglárka Brúgós +6 more
doaj +1 more source
ACR Open Rheumatology, Volume 8, Issue 6, June 2026.
Masaki Itagane, Mitsuyo Kinjo
wiley +1 more source
Targeted Therapy and Immunotherapies in Hepatocellular Carcinoma: Mechanisms and Clinical Studies
The mechanism of multiple signaling pathways and their related targeted inhibitors in HCC. (A) The mechanism of Ras/Raf/MEK/ERK signaling pathway and its related targeted inhibitors; (B) the mechanism of PI3K/AKT/mTOR signaling pathway and its crosstalk with other pathways and its related targeted inhibitors; (C) the mechanism of JAK/STAT signaling ...
Penghui He +9 more
wiley +1 more source
Intrathoracic Castleman disease
To analyze patients with Castleman disease who were diagnosed by surgery.We retrospectively investigated the postoperative pathological records of operations performed between January 1992 and December 2012 in our hospital. Files of 19 patients with the diagnosis of Castleman disease were analyzed.There were 13 male and 6 female patients with a mean ...
Karaoğlanoğlu, NURETTİN +6 more
openaire +3 more sources
Castleman's Disease in an Adolescent
Castleman’s disease is a clinic-pathological entity of unknown etiology with non–neoplastic lymph node hyperplasia. It is extremely rare and can be found in patients of all age groups. It can present as localized with local signs and symptoms or disseminated disease which includes a wide range of systemic problems.
Ujjwala Singh +3 more
openaire +2 more sources
Biopharmaceuticals for Cancer Treatment: An Update
ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Anupom Deb Nath +6 more
wiley +1 more source

